GlassScriptPhysician profile
Ginger Sue Carmichael
NPI 1760974018
$1,188.42
in general payments reported to CMS, 2019-2025
11 companies · $429 in 2025
The $429 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $114 · 2022: $95.58 · 2023: $139 · 2024: $410 · 2025: $429.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $758 · Food and Beverage: $221.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $757.93 |
| Food and Beverage | $220.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $757.93 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $117.48 | 2023 | Lynparza, Keytruda |
| Kite Pharma, INC. | $95.58 | 2022 | |
| Array Biopharma INC | $45.20 | 2023-2025 | Mektovi, Braftovi, Lorbrena |
| Ucb, INC. | $40.59 | 2021 | |
| Glaxosmithkline, LLC. | $36.67 | 2021 | |
| Incyte Corporation | $23.99 | 2025 | Monjuvi |
| Biogen, INC. | $22.08 | 2021 | |
| Emd Serono, INC. | $18.42 | 2024 | |
| Exelixis INC. | $15.79 | 2025 | Cabometyx |
| Amgen INC. | $14.69 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ginger Carmichael listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.